These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 39367352)
21. Prevalence of antiretroviral therapy treatment failure among HIV-infected pregnant women at first antenatal care: PMTCT Option B+ in Malawi. Chagomerana MB; Miller WC; Tang JH; Hoffman IF; Harrington BJ; DiPrete B; Wallie S; Jumbe A; Limarzi L; Hosseinipour MC PLoS One; 2018; 13(12):e0209052. PubMed ID: 30543685 [TBL] [Abstract][Full Text] [Related]
22. Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study. Phillips T; Thebus E; Bekker LG; Mcintyre J; Abrams EJ; Myer L J Int AIDS Soc; 2014; 17(1):19242. PubMed ID: 25301494 [TBL] [Abstract][Full Text] [Related]
23. The Effect of a Continuous Quality Improvement Intervention on Retention-In-Care at 6 Months Postpartum in a PMTCT Program in Northern Nigeria: Results of a Cluster Randomized Controlled Study. Oyeledun B; Phillips A; Oronsaye F; Alo OD; Shaffer N; Osibo B; Imarhiagbe C; Ogirima F; Ajibola A; Ezebuka O; Ojong-Etta B; Obi A; Falade J; Uthman AK; Famuyide B; Odoh D; Becquet R J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S156-S164. PubMed ID: 28498185 [TBL] [Abstract][Full Text] [Related]
24. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study. Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993 [TBL] [Abstract][Full Text] [Related]
25. Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study. Hosseinipour M; Nelson JAE; Trapence C; Rutstein SE; Kasende F; Kayoyo V; Kaunda-Khangamwa B; Compliment K; Stanley C; Cataldo F; van Lettow M; Rosenberg NE; Tweya H; Gugsa S; Sampathkumar V; Schouten E; Eliya M; Chimbwandira F; Chiwaula L; Kapito-Tembo A; Phiri S; J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2(Suppl 2):S149-S155. PubMed ID: 28498184 [TBL] [Abstract][Full Text] [Related]
26. Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi. Tweya H; Gugsa S; Hosseinipour M; Speight C; Ng'ambi W; Bokosi M; Chikonda J; Chauma A; Khomani P; Phoso M; Mtande T; Phiri S Trop Med Int Health; 2014 Nov; 19(11):1360-6. PubMed ID: 25087778 [TBL] [Abstract][Full Text] [Related]
27. Characteristics and outcomes of women initiating ART during pregnancy versus breastfeeding in Option B+ in Malawi. Landes M; Sodhi S; Matengeni A; Meaney C; van Lettow M; Chan AK; van Oosterhout JJ BMC Public Health; 2016 Aug; 15():713. PubMed ID: 27487775 [TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz. Harrington BJ; DiPrete BL; Jumbe AN; Ngongondo M; Limarzi L; Wallie SD; Chagomerana MB; Hosseinipour MC; Trop Med Int Health; 2019 Oct; 24(10):1221-1228. PubMed ID: 31381233 [TBL] [Abstract][Full Text] [Related]
29. Uptake of prevention of mother-to-child-transmission using Option B+ in northern rural Malawi: a retrospective cohort study. Price AJ; Kayange M; Zaba B; Chimbwandira FM; Jahn A; Chirwa Z; Dasgupta AN; Katundu C; Saul JL; Glynn JR; Koole O; Crampin AC Sex Transm Infect; 2014 Jun; 90(4):309-14. PubMed ID: 24714445 [TBL] [Abstract][Full Text] [Related]
30. The impact of same-day antiretroviral therapy initiation on retention in care and clinical outcomes at four eThekwini clinics, KwaZulu-Natal, South Africa. Govere SM; Kalinda C; Chimbari MJ BMC Health Serv Res; 2023 Aug; 23(1):838. PubMed ID: 37553685 [TBL] [Abstract][Full Text] [Related]
31. Mother-infant pair clinic and SMS messaging as innovative strategies for improving access to and retention in eMTCT care and Option B+ in Malawi: a cluster randomized control trial (the PRIME study). Mwapasa V; Pro G; Chinkhumba J; Mukaka M; Kobayashi E; Stuart A; Gunda A; Joseph J; Sugandhi N; Chimbwandira FM; Eliya M J Acquir Immune Defic Syndr; 2014 Nov; 67 Suppl 2():S120-4. PubMed ID: 25310117 [TBL] [Abstract][Full Text] [Related]
32. Antiretroviral therapy retention, adherence, and clinical outcomes among postpartum women with HIV in Nigeria. Young CM; Chang CA; Sagay AS; Imade G; Ogunsola OO; Okonkwo P; Kanki PJ PLoS One; 2024; 19(8):e0302920. PubMed ID: 39110750 [TBL] [Abstract][Full Text] [Related]
33. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa. Fox MP; Pascoe S; Huber AN; Murphy J; Phokojoe M; Gorgens M; Rosen S; Wilson D; Pillay Y; Fraser-Hurt N PLoS Med; 2019 Jul; 16(7):e1002874. PubMed ID: 31335865 [TBL] [Abstract][Full Text] [Related]
34. Transitioning young adults from paediatric to adult care and the HIV care continuum in Atlanta, Georgia, USA: a retrospective cohort study. Hussen SA; Chakraborty R; Knezevic A; Camacho-Gonzalez A; Huang E; Stephenson R; Del Rio C J Int AIDS Soc; 2017 Sep; 20(1):21848. PubMed ID: 28872281 [TBL] [Abstract][Full Text] [Related]
35. Towards elimination of mother-to-child transmission of HIV: performance of different models of care for initiating lifelong antiretroviral therapy for pregnant women in Malawi (Option B+). van Lettow M; Bedell R; Mayuni I; Mateyu G; Landes M; Chan AK; van Schoor V; Beyene T; Harries AD; Chu S; Mganga A; van Oosterhout JJ J Int AIDS Soc; 2014; 17(1):18994. PubMed ID: 25079437 [TBL] [Abstract][Full Text] [Related]
36. Depression, retention in care, and uptake of PMTCT service in Kinshasa, the Democratic Republic of Congo: a prospective cohort. Yotebieng KA; Fokong K; Yotebieng M AIDS Care; 2017 Mar; 29(3):285-289. PubMed ID: 27819151 [TBL] [Abstract][Full Text] [Related]
37. HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI-PMTCT study. Yotebieng M; Mpody C; Ravelomanana NL; Tabala M; Malongo F; Kawende B; Ntangu P; Behets F; Okitolonda E; J Int AIDS Soc; 2019 Sep; 22(9):e25376. PubMed ID: 31496051 [TBL] [Abstract][Full Text] [Related]
38. Factors associated with non-attendance at scheduled infant follow-up visits in an observational cohort of HIV-exposed infants in South Africa, 2012-2014. Ngandu NK; Jackson D; Lombard C; Nsibande DF; Dinh TH; Magasana V; Mogashoa M; Goga AE BMC Infect Dis; 2019 Sep; 19(Suppl 1):788. PubMed ID: 31526372 [TBL] [Abstract][Full Text] [Related]
39. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi. Weigel R; Hosseinipour MC; Feldacker C; Gareta D; Tweya H; Chiwoko J; Gumulira J; Kalulu M; Mofolo I; Kamanga E; Mwale G; Kadzakumanja A; Jere E; Phiri S Trop Med Int Health; 2012 Jun; 17(6):751-9. PubMed ID: 22487553 [TBL] [Abstract][Full Text] [Related]
40. Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach. Sikazwe I; Eshun-Wilson I; Sikombe K; Czaicki N; Somwe P; Mody A; Simbeza S; Glidden DV; Chizema E; Mulenga LB; Padian N; Duncombe CJ; Bolton-Moore C; Beres LK; Holmes CB; Geng E PLoS Med; 2019 May; 16(5):e1002811. PubMed ID: 31150380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]